ATE488582T1 - Verfahren zur reinigung von faktor ix - Google Patents

Verfahren zur reinigung von faktor ix

Info

Publication number
ATE488582T1
ATE488582T1 AT05012614T AT05012614T ATE488582T1 AT E488582 T1 ATE488582 T1 AT E488582T1 AT 05012614 T AT05012614 T AT 05012614T AT 05012614 T AT05012614 T AT 05012614T AT E488582 T1 ATE488582 T1 AT E488582T1
Authority
AT
Austria
Prior art keywords
purifying factor
factor
hydroxyapatite
resins
purification
Prior art date
Application number
AT05012614T
Other languages
English (en)
Inventor
Barry W Foster
Robert J Costigan
Duane Bonam
Mary B Switzer
Rochelle Walsh
Original Assignee
Genetics Inst Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc filed Critical Genetics Inst Llc
Application granted granted Critical
Publication of ATE488582T1 publication Critical patent/ATE488582T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT05012614T 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor ix ATE488582T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/472,823 US5714583A (en) 1995-06-07 1995-06-07 Factor IX purification methods

Publications (1)

Publication Number Publication Date
ATE488582T1 true ATE488582T1 (de) 2010-12-15

Family

ID=23877079

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05012614T ATE488582T1 (de) 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor ix
AT96915892T ATE393217T1 (de) 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor-ix

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96915892T ATE393217T1 (de) 1995-06-07 1996-05-21 Verfahren zur reinigung von faktor-ix

Country Status (11)

Country Link
US (2) US5714583A (de)
EP (2) EP0832200B1 (de)
JP (1) JP3676817B2 (de)
AT (2) ATE488582T1 (de)
AU (1) AU5754396A (de)
CA (1) CA2220501C (de)
DE (2) DE69637509T2 (de)
DK (2) DK0832200T3 (de)
ES (2) ES2306450T3 (de)
PT (2) PT1571208E (de)
WO (1) WO1996040883A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
AU689184B2 (en) 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US20030036629A1 (en) * 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
ES2292682T3 (es) 1998-05-06 2008-03-16 Genentech, Inc. Purificacion de anticuerpos mediante cromatografia de intercambio ionico.
MXPA01002898A (es) 1998-09-21 2002-06-04 Genetics Inst Metodos de modulacion descendente de la respuesta inmune a proteinas terapeuticas.
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP2286847A1 (de) 1999-10-15 2011-02-23 Genetics Institute, LLC Hyaluronsäure enthaltende Zusammensetzungen zur Abgabe osteogener Proteine
WO2002039951A2 (en) * 2000-11-15 2002-05-23 Globe Immune, Inc. Yeast-dentritic cell vaccines and uses thereof
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
KR100451308B1 (ko) * 2001-12-28 2004-10-06 선바이오(주) 단백질 의약품 정제 방법에서의 바이러스 제거 방법
AU2004230670B2 (en) * 2003-01-09 2010-11-25 Genentech, Inc. Purification of polypeptides
CA2520970A1 (en) * 2003-04-09 2004-10-28 Robert G. Schaub Hemophilia treatment by inhalation of coagulation factors
WO2006005058A2 (en) * 2004-06-30 2006-01-12 Nektar Therapeutics Al, Corporation Polymer-factor ix moiety conjugates
PL1969127T5 (pl) 2005-12-21 2018-02-28 Cnj Holdings, Inc Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji
HRP20160990T1 (hr) 2006-03-24 2016-10-07 Biogen Hemophilia Inc. Pc5 kao enzim obrade faktor ix propeptida
EP2125866B1 (de) * 2007-02-28 2013-05-22 Baxter International Inc. Verfahren zur reinigung von mit sulfatierten und/oder phosphorylierten molekülen angereichtem rekombinantem blutgerinnungsfaktor ix
AU2008245524A1 (en) * 2007-04-26 2008-11-06 Cnj Holdings, Inc. Recombinant vitamin K dependent proteins with high sialic acid content and methods of preparing same
RU2353386C1 (ru) * 2007-10-11 2009-04-27 Общество с ограниченной ответственностью "БиоГениус" Способ получения концентрата ix фактора свертывания крови человека
BRPI0817182A2 (pt) 2007-10-30 2015-03-17 Genentech Inc Método para purificar um anticorpo e composições
US20110166332A1 (en) * 2008-09-12 2011-07-07 Ge Healthcare Bio-Sciences Ab Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
FR2946348B1 (fr) 2009-06-05 2011-08-05 Lab Francais Du Fractionnement Procede de preparation d'une composition de complexe prothrombique a haut degre de purete
DK2451963T3 (da) 2009-07-10 2014-08-04 Csl Ltd Fremgangsmåde til forøgelse afvitamin-k-afhængige proteiners exprimerings-ydelse
JP5851410B2 (ja) 2009-10-30 2016-02-03 シーエヌジェイ ホールディングス、インク． 組換えビタミンｋ依存性タンパク質の生成法
WO2011064247A1 (en) 2009-11-24 2011-06-03 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
RU2590726C2 (ru) * 2010-03-30 2016-07-10 Октафарма Аг Способ очистки витамин к-зависимых белков, таких как коагуляционный фактор ix
DK2552948T3 (en) 2010-03-30 2016-10-17 Octapharma Ag A process for the purification of the protein growth factor G-CSF
PT2563805T (pt) * 2010-04-29 2020-05-18 Baxalta Inc Método de purificação de proteínas que se ligam a catiões divalentes em resina de permuta aniónica
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
WO2013036445A1 (en) 2011-09-06 2013-03-14 Medimmune Llc Methods for processing coagulation factors
EP2748179B1 (de) * 2011-10-14 2021-12-29 Takeda Pharmaceutical Company Limited Proteinaufreinigung mithilfe der anionenausctauschchromatographie
AU2012322949B2 (en) * 2011-10-14 2015-07-02 Takeda Pharmaceutical Company Limited Protein purification by anion exchange chromatography
DK2970376T3 (en) 2013-03-15 2018-07-02 Baxalta Inc PURIFICATION PROCEDURE FOR VITAMIN K-DEPENDENT PROTEINS BY ANION EXCHANGE CHROMATOGRAPHY
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
CN114134109B (zh) * 2021-12-10 2023-01-24 广州远想生物科技股份有限公司 Egf间充质干细胞外泌体的纯化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4447416A (en) * 1982-04-28 1984-05-08 American National Red Cross Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy
US5055557A (en) * 1983-03-04 1991-10-08 Scripps Clinic & Research Foundation Ultrapurification of factor IX and other vitamin K-dependent proteins
EP0162078B1 (de) * 1983-10-28 1994-09-14 New England Medical Center Hospitals, Inc. VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
US4831118A (en) * 1987-08-07 1989-05-16 Scripps Clinic And Research Foundation Flouroplastic immunoaffinity columns for purification of blood proteins
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
WO1989005652A1 (en) * 1987-12-21 1989-06-29 American National Red Cross Pure factor ix product
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
CA1330302C (en) * 1988-01-18 1994-06-21 Miroslav Rybak Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
DE3826792C1 (de) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DE3914869C1 (de) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5714583A (en) * 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods

Also Published As

Publication number Publication date
ES2306450T3 (es) 2008-11-01
DE69637509D1 (de) 2008-06-05
CA2220501C (en) 2014-01-07
JPH11506603A (ja) 1999-06-15
AU5754396A (en) 1996-12-30
CA2220501A1 (en) 1996-12-19
DK0832200T3 (da) 2008-07-21
DK1571208T3 (da) 2011-01-24
EP1571208A1 (de) 2005-09-07
PT832200E (pt) 2008-07-17
EP1571208B1 (de) 2010-11-17
DE69637509T2 (de) 2009-05-28
WO1996040883A1 (en) 1996-12-19
US5714583A (en) 1998-02-03
PT1571208E (pt) 2011-01-04
JP3676817B2 (ja) 2005-07-27
EP0832200A1 (de) 1998-04-01
ATE393217T1 (de) 2008-05-15
US6627737B1 (en) 2003-09-30
ES2353798T3 (es) 2011-03-07
DE69638291D1 (de) 2010-12-30
EP0832200B1 (de) 2008-04-23

Similar Documents

Publication Publication Date Title
ATE488582T1 (de) Verfahren zur reinigung von faktor ix
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DE58902183D1 (de) Verfahren zur reinigung von rohem, gasfoermigem chlorwasserstoff.
DE69841047D1 (de) Verfahren zur Regenerierung von Epoxidierungskatalysatoren
DE69715234D1 (de) Verfahren zur reinigung von 1,1-difluorethan
DE69400257D1 (de) Verfahren zur Reinigung von Pentafluorethan
DE69504433D1 (de) Verfahren zur Herstellung von korrosionsbeständigen, porösen metallischen Bauteilen
DE59603541D1 (de) Verfahren zur Reinigung von Bisphenol-A
DE3587298D1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
ATA18695A (de) Verfahren zur reinigung von melamin
DE69502313D1 (de) Verfahren zur biologischen Reinigung von Gasströmen
DE68901643D1 (de) Verfahren zur beschichtung von kohlenstoffkoerpern.
DE69003423D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
DE59002817D1 (de) Verfahren zur kontinuierlichen Reinigung von Caprolactam.
DE69522807D1 (de) Verfahren zur herstellung von feinkörnigen, modifizierten stärken
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
DE69612674D1 (de) Verfahren zur entsalzung, und demineralisierung von säure und/oder metallsalzen enthaltenden lösungen
DE59102062D1 (de) Verfahren zur biologischen Reinigung von Abluftströmen.
ATE118498T1 (de) Verfahren zur reinigung von n- phosphonmethylglyzin.
DE69008825D1 (de) Verfahren zur Reinigung von Phagen-DNA.
DE69304638D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan
DE69719247D1 (de) Ionenaustauscher, Verfahren zu dessen Herstellung und Verwendung desselben zur Entfernung von mehrwertigen Anionen
DE69501300D1 (de) Verfahren zur reinigung von fluormethyl-1,1,1,3,3,3-hexafluorisopropylether
DE69300901D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
ATE240969T1 (de) VERFAHREN ZUR REINIGUNG VON ßBASICß FIBROBLASTEN WACHSTUMSFAKTOR

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1571208

Country of ref document: EP